trump glp 1 announcement The administration announced price cuts for GLP-1 weight-loss drugs Zepbound and Wegovy, with direct-to-consumer access via TrumpRX in 2026. #trump #politicsnews #GLP1 JUST IN: President Trump announced

Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss

Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline

Consistent use of GLP-1 support contributes to overall wellness, metabolic efficiency, and sustained vitality

Rybelsus and Farxiga treat Type 2 diabetes, but one has more approved uses, among other differences, such as cost and side effects.

As fatty liver disease continues to drive downstream costs, this signal is getting serious attention

This approachable, delicious option aims to fit into real lifedelivering a sensory-friendly bite with a taste of yuzu and a commitment to clean, plant-forward ingredients